Home > Insider Trading > Filing (0001225208-10-016021)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
901219	Human Genome Sciences Inc	HGSI	In Vitro & In Vivo Diagnostic Substances (2835)	223178468

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1184419	Jurgen Drews	14200 Shady Grove Road Rockville MD 20850		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2010-06-30	20,732	$10.69	30,773	No	4	M	Direct
Common Stock	Acquisiton	2010-06-30	11,120	$5.97	41,893	No	4	M	Direct
Common Stock	Acquisiton	2010-06-30	5,782	$2.09	47,675	No	4	M	Direct
Common Stock	Disposition	2010-06-30	300	$23.55	47,375	No	4	S	Direct
Common Stock	Disposition	2010-06-30	5,782	$23.34	41,593	No	4	S	Direct
Common Stock	Disposition	2010-06-30	11,120	$23.39	30,473	No	4	S	Direct
Common Stock	Disposition	2010-06-30	20,432	$23.18	10,041	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Employee Director Stock Option - Right to Buy	Disposition	2010-06-30	20,732	$0.00	20,732	$10.69
Common Stock	Non-Employee Director Stock Option - Right to Buy	Disposition	2010-06-30	11,120	$0.00	11,120	$5.97
Common Stock	Non-Employee Director Stock Option - Right to Buy	Disposition	2010-06-30	5,782	$0.00	5,782	$2.09

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2014-05-21	No	4	M	Direct
4,880	2018-05-08	No	4	M	Direct
10,218	2019-05-07	No	4	M	Direct

Footnotes

This transaction was executed in multiple trades at 23.55. The price reported above reflects the weighted average sale price. Upon written request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price is available.
This transaction was executed in multiple trades at prices ranging from $22.91 to $23.63. The price reported above reflects the weighted average sale price. Upon written request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price is available.
This transaction was executed in multiple trades at prices ranging from $22.91 to $23.69. The price reported above reflects the weighted average sale price. Upon written request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price is available.
This transaction was executed in multiple trades at prices ranging from $22.53 to $23.51. The price reported above reflects the weighted average sale price. Upon written request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price is available.
These options have vested and are fully exercisable.